Trial intelligence / Profile preview

Licart Topical System in Minor Soft Tissue Injuries

NCT05171673Phase 3Completed

Sponsor
IBSA Group
Start
Oct 2021
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Elfenor in soft tissue injury, sponsored by IBSA Group. Started Oct 2021; status: completed.

02

Drugs

Elfenor
03

Conditions

soft tissue injury

Beyond the preview

Go deeper on NCT05171673.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05171673.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call